Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity

Glioblastoma (GBM) is a heterogeneous tumor of the brain with a poor prognosis due to recurrence and drug resistance following therapy. Genome-wide profiling has revealed the existence of distinct GBM molecular subtypes that respond differently to aggressive therapies. Despite this, molecular subtyp...

Descripción completa

Detalles Bibliográficos
Autores principales: Brown, Daniel V., Filiz, Gulay, Daniel, Paul M., Hollande, Frédéric, Dworkin, Sebastian, Amiridis, Stephanie, Kountouri, Nicole, Ng, Wayne, Morokoff, Andrew P., Mantamadiotis, Theo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328356/
https://www.ncbi.nlm.nih.gov/pubmed/28241049
http://dx.doi.org/10.1371/journal.pone.0172791

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5328356/
https://www.ncbi.nlm.nih.gov/pubmed/28241049
http://dx.doi.org/10.1371/journal.pone.0172791

Ejemplares similares